Paasa Logo
Invesco NASDAQ Biotech UCITS ETF logo
SBIOLSEMarket closedOpens 8:00am UK

Invesco NASDAQ Biotech UCITS ETF

$74.70Last updated
+$1.18 (1.61%)Past day
Timezone

Invesco NASDAQ Biotech UCITS ETF (LSE: SBIO) is an exchange-traded fund listed on the London Stock Exchange ETF segment, trading at $74.70 (about ₹7,176 a unit) as of 30 Sep 2026, 11:35 AM ET. It has an expense ratio of 0.4%. Indian residents can buy SBIO through Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$74.48
Previous close:$73.52
Volume:21.03K

Today's low

$73.88

Today's high

$74.81

52 week low

$50.27

52 week high

$77.12

SBIO opened at $74.48, closed previously at $73.52, and has traded between $50.27 and $77.12 over the past 52 weeks.

About

This Exchange-Traded Fund (ETF) employs a passive management strategy, with its primary goal being to replicate the comprehensive total return performance of the NASDAQ Biotechnology Index. Investors should note that their net returns will be calculated after the deduction of management fees, operational expenses, and transaction costs.

Issuer
Invesco
Exchange listed on
LSE
Asset class
Equity
Base currency
USD
Domicile
Ireland
Dividends
—
Launched
2014
ISIN
IE00BQ70R696

Key statistics

Expense ratio

0.4%

Assets (AUM)

$499.4M

Holdings

—

NAV

$74.21

Avg. volume

—

1-year price change

+48.48%

5-year price change

+42.53%

Price change excludes dividends.

Top 10 holdings

1. GILEAD SCIENCES ORD
8.3%
2. AMGEN ORD
7.8%
3. VERTEX PHARMACEUTICALS ORD
7.7%
4. MODERNA ORD
5.2%
5. REGENERON PHARMACEUTICALS ORD
5.0%
6. REVOLUTION MEDICINES ORD
2.8%
7. ILLUMINA ORD
2.7%
8. ALNYLAM PHARMACEUTICALS ORD
2.2%
9. BIOGEN ORD
2.2%
10. ROIVANT SCIENCES ORD
1.7%

These 10 are 45.7% of the fund.

Where the money is invested

Countries

United States
88.5%
United Kingdom
2.4%
Netherlands
2.3%
Ireland
1.6%
Switzerland
1.3%
Denmark
1.1%

How to buy SBIO from India

Indian residents can buy SBIO units through Paasa in three steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the units are held in your own name with Interactive Brokers.

  1. Open your Paasa account

    KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds from your Indian bank account

    Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit.

  3. Search SBIO and buy

    Find the fund by its ticker, SBIO, on the London Stock Exchange ETF segment, and place your order.

Read the full guide: how to invest in SBIO from India

Trading and taxes when buying SBIO from India

Trading and limits

Trading hours
8:00 am – 4:30 pm UK
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on foreign ETF units held for more than 24 months are long-term and taxed at 12.5% without indexation. Gains on units held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained

Custody. Units are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

What is the SBIO price today?

Invesco NASDAQ Biotech UCITS ETF (SBIO) last traded at $74.70 on the London Stock Exchange ETF segment, as of 30 Sep 2026, 11:35 AM ET. That is ₹7,176 a unit at the 29 Sep 2026 USD/INR rate.

When does SBIO trade, in Indian time?

The London Stock Exchange ETF segment trades 12:30 pm – 9:00 pm IST. The window shifts to 1:30 pm – 10:00 pm IST when the UK is on standard time. Orders can only execute during that window.

How big is SBIO, and what does it cost to hold?

Invesco NASDAQ Biotech UCITS ETF manages about $499.4M. Its expense ratio is 0.4% a year, deducted inside the fund. It launched in 2014.

Is SBIO a UCITS ETF?

Yes. Invesco NASDAQ Biotech UCITS ETF is a UCITS fund domiciled in Ireland, set up under the European Union's UCITS rules for funds sold across Europe. It is listed on the London Stock Exchange ETF segment and trades in US dollars.

What are SBIO's largest holdings?

The top three are GILEAD SCIENCES ORD (8.3%), AMGEN ORD (7.8%) and VERTEX PHARMACEUTICALS ORD (7.7%). SBIO's 10 largest positions make up 45.7% of the fund.

Is SBIO subject to US estate tax?

No. Because SBIO is domiciled in Ireland rather than the US, it is not a US-situs asset, so US estate tax does not apply to it. US-listed ETFs held directly can be taxed at up to 40% above $60,000 when they pass to your family.

How are US dividends taxed inside SBIO?

The US withholds 15% on dividends from the US shares the fund holds, and that tax is paid inside the fund. You cannot claim it as a Foreign Tax Credit in India.

How are gains on SBIO taxed in India?

Units held for more than 24 months are long-term and taxed at 12.5% without indexation; units held for 24 months or less are taxed at your income-tax slab rate. The gain is worked out in rupees, so the currency move counts.

How has SBIO performed?

SBIO's price is up 48.5% over the past year and up 42.5% over five years. These figures are price change only and exclude dividends; past performance does not guarantee future returns.

How is SBIO different from a US-listed ETF?

SBIO is domiciled in Ireland rather than the US. That keeps it outside US estate tax, and dividend withholding on its US shares is 15%, paid inside the fund, instead of the 25% withheld on a US-listed ETF. The 25% can generally be claimed as a credit in India; the 15% cannot. Capital gains on both are taxed the same way in India.